Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Steenbruggen TG, Bouwer NI, Smorenburg CH, Rier HN, Jager A, Beelen K, Ten Tije AJ, de Jong PC, Drooger JC, Holterhues C, Kitzen JJEM, Levin M-, Sonke GS. Steenbruggen TG, et al. Among authors: holterhues c. Breast Cancer Res Treat. 2019 Dec;178(3):597-605. doi: 10.1007/s10549-019-05427-1. Epub 2019 Sep 6. Breast Cancer Res Treat. 2019. PMID: 31493033
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
Bouwer NI, Steenbruggen TG, van Rosmalen J, Rier HN, Kitzen JJEM, van Bekkum ML, Tije AJT, de Jong PC, Drooger JC, Holterhues C, Smorenburg CH, Kofflard MJM, Boersma E, Sonke GS, Levin MD, Jager A. Bouwer NI, et al. Among authors: holterhues c. Breast Cancer Res Treat. 2021 Apr;186(3):851-862. doi: 10.1007/s10549-020-06039-w. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33394273 Free PMC article.
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.
Bouwer NI, Steenbruggen TG, Rier HN, Kitzen JJEM, Smorenburg CH, van Bekkum ML, de Jong PC, Drooger JC, Holterhues C, Kofflard MJM, Boersma E, Sonke GS, Levin MD, Jager A. Bouwer NI, et al. Among authors: holterhues c. Int J Cancer. 2022 Aug 15;151(4):616-622. doi: 10.1002/ijc.34024. Epub 2022 Apr 27. Int J Cancer. 2022. PMID: 35403708 Free PMC article.
Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population-based study.
Baltussen JC, de Glas NA, Liefers GJ, Slingerland M, Speetjens FM, van den Bos F, Cloos-van Balen M, Verschoor AJ, Jochems A, Spierings LEAMM, Holterhues C, van Gerven LA, Mooijaart SP, Portielje JEA, Derks MGM. Baltussen JC, et al. Among authors: holterhues c. Int J Cancer. 2023 May 15;152(10):2043-2051. doi: 10.1002/ijc.34422. Epub 2023 Jan 13. Int J Cancer. 2023. PMID: 36620951
Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients.
Baltussen JC, de Glas NA, van Holstein Y, van der Elst M, Trompet S, Uit den Boogaard A, van der Plas-Krijgsman W, Labots G, Holterhues C, van der Bol JM, Mammatas LH, Liefers GJ, Slingerland M, van den Bos F, Mooijaart SP, Portielje JEA. Baltussen JC, et al. Among authors: holterhues c. JAMA Netw Open. 2023 Oct 2;6(10):e2339116. doi: 10.1001/jamanetworkopen.2023.39116. JAMA Netw Open. 2023. PMID: 37870832 Free PMC article.
18 results